SGMO: Interesting accumulation base...
Updated
Sangamo Therapeutics, Inc. is a company that develops genomic therapies, using genome editing, gene therapy, gene regulation, and cell therapy. It's an interesting addition to your swing trading portfolio, specially now that it is ready to start trending up after being accumulated after enduring an extensive correction, now trading at a 40% discount from recent highs. Price held support at the earnings key level depicted by a green horizontal ray on chart. These levels offer a crucial map for price action, that helps us determine where to act, or what to expect as far as potential upside or downside a stock has, with very good reliability. This is one of timwest's tools that you can leverage in your own trading and investing if using the Key Hidden Levels indicator pack (after learning how to use it of course).
If the market trends up from here confirming the daily time at mode signal on chart we can expect a 20 day rally reaching the targets on chart, potentially, or even higher levels if it holds once this rally expires, and is reaccumulated at higher levels once more. We hold positions in this stock, and would hold and even add if feasible in the coming days.
Best of luck if taking the trade.
Cheers,
Ivan Labrie.
If the market trends up from here confirming the daily time at mode signal on chart we can expect a 20 day rally reaching the targets on chart, potentially, or even higher levels if it holds once this rally expires, and is reaccumulated at higher levels once more. We hold positions in this stock, and would hold and even add if feasible in the coming days.
Best of luck if taking the trade.
Cheers,
Ivan Labrie.
Note
Weekly trend likely still up: Trade closed manually
Looks like it was a 'pump and dump' move practically... The upgrade helped the underwriters unload. Oh well, next...
🔒Want to dive deeper? Check out my paid services below🔒
ivanlabrie.substack.com/
ivanlabrie.substack.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.